CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: Genetic evaluation should include a three-generation family pedigree, histopathological confirmation of DGC diagnoses or precursor lesions, and a discussion of lifetime risks of DGC and LBC and current CDH1 mutation detection rates [11,12,50].